GSK plc (GSK) News
Follow GSK plc (GSK) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 272 public stories across 54 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
GSK and Moderna Settle Patent Dispute Over COVID and RSV Shots
The companies settled GSK lawsuits alleging that Moderna’s Spikevax and mNEXSPIKE COVID-19 vaccines and mResvia RSV shot infringed its patents.
EQUITY | Nov 06, 2026, 06:12 PM UTC
M
European session market picture: S&P 500 +0.25%, Nasdaq 100 +1.37%; EUR/USD -0.37%, WTI +0.22%, LLOY leads volume
European session market picture. US index futures: S and P futures is up 0.25 percent, Nasdaq futures is up 1.37 percent, Dow futures is down 0.92 percent and Russell futures is down 0.03 percent. In currencies, the doll
EQUITY | Nov 06, 2026, 11:01 AM UTC
M
Stoxx Europe 600 Health Care Index Falls 2.1% in Selloff
The index is one of the worst-performing sector indexes as healthcare stocks join a wider market decline. Wealth Club's Susannah Streeter says profit-taking after recent sector gains may be a factor.
EQUITY | Nov 06, 2026, 10:05 AM UTC
M
European session market picture: S&P 500 +1.17%, Nasdaq 100 +0.35%; EUR/USD +0.63%, WTI -2.92%, LLOY leads volume
European session market picture. US index futures: S and P futures is up 1.17 percent, Nasdaq futures is up 0.35 percent, Dow futures is up 2.22 percent and Russell futures is up 1.81 percent. In currencies, the dollar i
EQUITY | Nov 04, 2026, 02:02 PM UTC
L
HP Names Former GSK CEO Emma Walmsley Chief Executive
HP said its board appointed former GSK CEO Emma Walmsley as chief executive.
EQUITY | Nov 04, 2026, 01:36 PM UTC
M
European session market picture: S&P 500 +0.76%, Nasdaq 100 -0.08%; EUR/USD +0.68%, WTI -1.43%, LLOY leads volume
European session market picture. US index futures: S and P futures is up 0.76 percent, Nasdaq futures is down 0.08 percent, Dow futures is up 1.66 percent and Russell futures is up 1.36 percent. In currencies, the dollar
EQUITY | Nov 04, 2026, 01:00 PM UTC
M
European session market picture: S&P 500 +0.96%, Nasdaq 100 +0.44%; EUR/USD +0.7%, WTI -1.49%, LLOY leads volume
European session market picture. US index futures: S and P futures is up 0.96 percent, Nasdaq futures is up 0.44 percent, Dow futures is up 1.7 percent and Russell futures is up 1.49 percent. In currencies, the dollar in
EQUITY | Nov 04, 2026, 12:32 PM UTC
M
European session market picture: S&P 500 +0.47%, Nasdaq 100 +0.35%; EUR/USD +0.6%, WTI -0.59%, LLOY leads volume
European session market picture. US index futures: S and P futures is up 0.47 percent, Nasdaq futures is up 0.35 percent, Dow futures is up 0.96 percent and Russell futures is up 1.07 percent. In currencies, the dollar i
EQUITY | Nov 04, 2026, 09:30 AM UTC
M
European session market picture: S&P 500 +0.23%, Nasdaq 100 +0.17%; EUR/USD +0.52%, WTI +0.06%, LLOY leads volume
European session market picture. US index futures: S and P futures is up 0.23 percent, Nasdaq futures is up 0.17 percent, Dow futures is up 0.55 percent and Russell futures is up 0.73 percent. In currencies, the dollar i
EQUITY | Nov 04, 2026, 09:00 AM UTC
M
European session market picture: S&P 500 -1.12%, Nasdaq 100 -2.56%; EUR/USD -0.13%, WTI +1.89%, LLOY leads volume
European session market picture. US index futures: S and P futures is down 1.12 percent, Nasdaq futures is down 2.56 percent, Dow futures is down 0.23 percent and Russell futures is down 0.64 percent. In currencies, the
EQUITY | Oct 30, 2026, 01:30 PM UTC
M
European session market picture: S&P 500 -1.07%, Nasdaq 100 -2.37%; EUR/USD +0.22%, WTI +2.1%, LLOY leads volume
European session market picture. US index futures: S and P futures is down 1.07 percent, Nasdaq futures is down 2.37 percent, Dow futures is down 0.05 percent and Russell futures is down 0.62 percent. In currencies, the
EQUITY | Oct 30, 2026, 10:30 AM UTC
M
European session market picture: S&P 500 -0.97%, Nasdaq 100 -2.18%; EUR/USD +0.16%, WTI +1.64%, LLOY leads volume
European session market picture. US index futures: S and P futures is down 0.97 percent, Nasdaq futures is down 2.18 percent, Dow futures is up 0.06 percent and Russell futures is down 0.46 percent. In currencies, the do
EQUITY | Oct 30, 2026, 09:30 AM UTC
M
European session market picture: S&P 500 -0.45%, Nasdaq 100 -1.3%; EUR/USD -0.06%, WTI -0.76%, LLOY leads volume
European session market picture. US index futures: S and P futures is down 0.45 percent, Nasdaq futures is down 1.3 percent, Dow futures is up 0.23 percent and Russell futures is up 0.35 percent. In currencies, the dolla
EQUITY | Oct 29, 2026, 08:00 AM UTC
M
European session market picture: S&P 500 +0.19%, Nasdaq 100 +0.3%; EUR/USD +0.06%, WTI +2.02%, LLOY leads volume
European session market picture. US index futures: S and P futures is up 0.19 percent, Nasdaq futures is up 0.3 percent, Dow futures is up 0.04 percent and Russell futures is up 0.09 percent. In currencies, the dollar in
EQUITY | Oct 28, 2026, 01:01 PM UTC
M
European session market picture: S&P 500 +0.23%, Nasdaq 100 +0.41%; EUR/USD +0.05%, WTI +1.94%, LLOY leads volume
European session market picture. US index futures: S and P futures is up 0.23 percent, Nasdaq futures is up 0.41 percent, Dow futures is up 0.02 percent and Russell futures is up 0.04 percent. In currencies, the dollar i
EQUITY | Oct 28, 2026, 12:31 PM UTC
M
GSK Shares Fall 7% After Shingrix Sales Disappoint
GSK reported lower-than-expected sales for its bestselling shingles vaccine, Shingrix, mainly due to weakness in China. Shares fell 7% in European midday trading Wednesday.
EARNINGS | Oct 28, 2026, 12:25 PM UTC
M
European session market picture: S&P 500 +0.1%, Nasdaq 100 +0.36%; EUR/USD +0.01%, WTI +2.02%, LLOY leads volume
European session market picture. US index futures: S and P futures is up 0.1 percent, Nasdaq futures is up 0.36 percent, Dow futures is down 0.26 percent and Russell futures is down 0.21 percent. In currencies, the dolla
EQUITY | Oct 28, 2026, 12:00 PM UTC
M
European session market picture: S&P 500 +0.12%, Nasdaq 100 +0.36%; EUR/USD -0.03%, WTI +1.77%, LLOY leads volume
European session market picture. US index futures: S and P futures is up 0.12 percent, Nasdaq futures is up 0.36 percent, Dow futures is down 0.22 percent and Russell futures is down 0.14 percent. In currencies, the doll
EQUITY | Oct 28, 2026, 11:30 AM UTC
M
European session market picture: S&P 500 +0.13%, Nasdaq 100 +0.45%; EUR/USD -0.04%, WTI +1.59%, LLOY leads volume
European session market picture. US index futures: S and P futures is up 0.13 percent, Nasdaq futures is up 0.45 percent, Dow futures is down 0.25 percent and Russell futures is down 0.17 percent. In currencies, the doll
EQUITY | Oct 28, 2026, 11:00 AM UTC
M
European session market picture: S&P 500 +0.12%, Nasdaq 100 +0.42%; EUR/USD -0.01%, WTI +1.64%, LLOY leads volume
European session market picture. US index futures: S and P futures is up 0.12 percent, Nasdaq futures is up 0.42 percent, Dow futures is down 0.24 percent and Russell futures is down 0.22 percent. In currencies, the doll
EQUITY | Oct 28, 2026, 10:30 AM UTC
M
FTSE 100 slips 0.3% as GSK and Unilever lead declines
The FTSE 100 fell 0.3% on Wednesday, with GSK and Unilever leading losses after quarterly results. Investors were also focused on finance minister John Healey's first budget and the US Federal Reserve's rate decision.
EQUITY | Oct 28, 2026, 10:14 AM UTC
M
European session market picture: S&P 500 +0.06%, Nasdaq 100 +0.32%; EUR/USD -0.04%, WTI +1.99%, LLOY leads volume
European session market picture. US index futures: S and P futures is up 0.06 percent, Nasdaq futures is up 0.32 percent, Dow futures is down 0.19 percent and Russell futures is down 0.12 percent. In currencies, the doll
EQUITY | Oct 28, 2026, 09:30 AM UTC
M
European session market picture: S&P 500 +0.08%, Nasdaq 100 +0.39%; EUR/USD -0.04%, WTI +1.8%, LLOY leads volume
European session market picture. US index futures: S and P futures is up 0.08 percent, Nasdaq futures is up 0.39 percent, Dow futures is down 0.17 percent and Russell futures is down 0.08 percent. In currencies, the doll
EQUITY | Oct 28, 2026, 09:01 AM UTC
M
GSK Q3 Core Earnings Edge Lower as Sales Increase; 2026 Outlook Affirmed
GSK reported Q3 core earnings of 0.546, while sales increased. The company affirmed its 2026 outlook.
EQUITY | Oct 28, 2026, 08:58 AM UTC
M
GSK Q3 Core Earnings Beat, but Shingrix Sales Weaken
J.P. Morgan analysts say GSK’s third-quarter core earnings beat expectations, largely due to cost timing, while Shingrix sales were weaker than expected. Quarterly turnover was 1% ahead.
EQUITY | Oct 28, 2026, 08:48 AM UTC
M
European session market picture: S&P 500 +0.07%, Nasdaq 100 +0.45%; EUR/USD -0.01%, WTI +1.43%, LLOY leads volume
European session market picture. US index futures: S and P futures is up 0.07 percent, Nasdaq futures is up 0.45 percent, Dow futures is down 0.22 percent and Russell futures is down 0.06 percent. In currencies, the doll
EQUITY | Oct 28, 2026, 08:30 AM UTC
M
GSK Reports Higher Third-Quarter Sales, Boosted by Specialty Medicines
GSK said third-quarter turnover was 8.89 billion pounds ($11.83 billion), with growth boosted by its specialty medicines segment.
EARNINGS | Oct 28, 2026, 07:46 AM UTC
M
GSK Reports Q3 2026 Sales of £8.9 Billion, Up 5%
GSK reported Q3 2026 sales of £8.9 billion, up 5%.
EQUITY | Oct 28, 2026, 07:32 AM UTC
M
GSK Reports Nine-Month 2026 Profit of USD 5.49 Billion
GSK reported turnover of USD 33.4 billion for the nine-month period.
EARNINGS | Oct 28, 2026, 07:25 AM UTC
M
GSK Reports Nine-Month 2026 Net Profit and Revenue
EARNINGS | Oct 28, 2026, 07:25 AM UTC
M
GSK reports third-quarter 2026 results
GSK published its third-quarter 2026 results report.
EQUITY | Oct 28, 2026, 07:20 AM UTC
M
GSK Q3 Profit Tops Estimates on Oncology Sales; Declares Dividend
EQUITY | Oct 28, 2026, 07:16 AM UTC
M
GSK 3Q Nucala Sales Reach GBP582M, Up 18% at Constant Currency
EARNINGS | Oct 28, 2026, 07:09 AM UTC
M
GSK 3Q Dovato Sales Rise 9% to GBP754M at Constant Currency
EQUITY | Oct 28, 2026, 07:08 AM UTC
M
GSK Beats Third-Quarter Profit Estimates, Keeps Annual Targets
GSK beat third-quarter sales and profit expectations, helped by demand for specialty medicines, and kept its annual targets.
EQUITY | Oct 28, 2026, 07:07 AM UTC
M
GSK Third-Quarter Shingrix Sales Fall 5% to GBP780M
GSK reported Shingrix sales of GBP780 million in the third quarter, down 5% at constant currency.
EQUITY | Oct 28, 2026, 07:06 AM UTC
M
GSK Q3 adjusted EPS was GBP 0.546
GSK reported Q3 adjusted EPS of GBP 0.546, compared with an IBES estimate of GBP 0.51.
EARNINGS | Oct 28, 2026, 07:04 AM UTC
M
GSK Reports Third-Quarter Core Operating Profit of GBP3.08B
EQUITY | Oct 28, 2026, 07:04 AM UTC
M
GSK Q3 Sales Reach GBP 8,887 Million
GSK reported Q3 sales of GBP 8,887 million, compared with an IBES estimate of GBP 8,821 million.
EARNINGS | Oct 28, 2026, 07:04 AM UTC
M
GSK Q3 Adjusted Operating Profit GBP 3,076 Million
GSK reported Q3 adjusted operating profit of GBP 3,076 million, versus an IBES estimate of GBP 2,960 million.
EQUITY | Oct 28, 2026, 07:04 AM UTC
M
GSK Sees FY Turnover Growth of 3–5%
EARNINGS | Oct 28, 2026, 07:04 AM UTC
M
European session market picture: S&P 500 +0.01%, Nasdaq 100 -0.02%; EUR/USD -0.19%, WTI +0.53%, LLOY leads volume
European session market picture. US index futures: S and P futures is up 0.01 percent, Nasdaq futures is down 0.02 percent, Dow futures is up 0.08 percent and Russell futures is up 0.01 percent. In currencies, the dollar
EQUITY | Oct 27, 2026, 09:00 AM UTC
L
GSK Sees Cancer-Drug Pipeline Nearly Doubling Next Year After Dealmaking Spree — WSJ
GSK Sees Cancer-Drug Pipeline Nearly Doubling Next Year After Dealmaking Spree — WSJ
NEWS | Oct 27, 2026, 07:40 AM UTC
M
GSK, Hansoh Drug Delays Bone Cancer Progression in China Study
Researchers presented late-stage study data showing the companies’ experimental drug helped patients live longer without their bone cancer worsening.
EQUITY | Oct 26, 2026, 03:30 PM UTC
L
GSK Says Jemperli Meets Primary Objective in Phase 2 Trial
GSK reported that its cancer drug Jemperli met its primary objective in a phase 2 trial.
EQUITY | Oct 26, 2026, 08:39 AM UTC
M
European session market picture: S&P 500 -0.49%, Nasdaq 100 -0.38%; EUR/USD -0.19%, WTI +2.21%, LLOY leads volume
European session market picture. US index futures: S and P futures is down 0.49 percent, Nasdaq futures is down 0.38 percent, Dow futures is down 0.88 percent and Russell futures is down 0.66 percent. In currencies, the
EQUITY | Oct 23, 2026, 01:30 PM UTC
M
European session market picture: S&P 500 -0.21%, Nasdaq 100 -0.02%; EUR/USD -0.17%, WTI +1.65%, LLOY leads volume
European session market picture. US index futures: S and P futures is down 0.21 percent, Nasdaq futures is down 0.02 percent, Dow futures is down 0.6 percent and Russell futures is down 0.52 percent. In currencies, the d
EQUITY | Oct 23, 2026, 10:02 AM UTC
M
European session market picture: S&P 500 -0.07%, Nasdaq 100 +0.13%; EUR/USD -0.19%, WTI +0.98%, LLOY leads volume
European session market picture. US index futures: S and P futures is down 0.07 percent, Nasdaq futures is up 0.13 percent, Dow futures is down 0.37 percent and Russell futures is down 0.33 percent. In currencies, the do
EQUITY | Oct 23, 2026, 08:00 AM UTC
M
European session market picture: S&P 500 +0.24%, Nasdaq 100 +0.51%; EUR/USD -0.13%, WTI +1.45%, LLOY leads volume
European session market picture. US index futures: S and P futures is up 0.24 percent, Nasdaq futures is up 0.51 percent, Dow futures is up 0.05 percent and Russell futures is down 0.01 percent. In currencies, the dollar
EQUITY | Oct 21, 2026, 10:01 AM UTC
M
GSK Wins US Approval for Hepatitis B Drug Hibsago
GSK said Hibsago was cleared under priority review and breakthrough therapy designation. Phase III B—Well data supported the decision, according to the company.
REGULATION | Oct 21, 2026, 09:13 AM UTC
M
FDA Approves GSK’s Hibsago for Chronic Hepatitis B Treatment
GSK announced that the FDA approved Hibsago (bepirovirsen) for chronic hepatitis B treatment in the U.S.
REGULATION | Oct 21, 2026, 01:20 AM UTC
M
HUTCHMED Closes License Deal With GSK Outside China
HUTCHMED says customary closing conditions have been completed for its license of a KRAS-EGFR-antibody conjugate therapy to GSK outside China.
MNA | Oct 21, 2026, 12:04 AM UTC
M
FDA Approves GSK’s Hibsago for Chronic Hepatitis B
The FDA approved Hibsago (bepirovirsen) for chronic hepatitis B in adults receiving nucleos(t)ide analogue reverse transcriptase inhibitor therapy.
REGULATION | Oct 20, 2026, 11:58 PM UTC
M
FDA Approves GSK Hepatitis B Drug Hibsago
The FDA approved Hibsago, also known as bepirovirsen, for hepatitis B. GSK said the drug may help patients keep the virus under control after stopping treatment.
REGULATION | Oct 20, 2026, 08:01 PM UTC
M
European session market picture: S&P 500 -0.09%, Nasdaq 100 -0.46%; EUR/USD +0.01%, WTI +2.35%, LLOY leads volume
European session market picture. US index futures: S and P futures is down 0.09 percent, Nasdaq futures is down 0.46 percent, Dow futures is up 0.18 percent and Russell futures is down 0.04 percent. In currencies, the do
EQUITY | Oct 20, 2026, 10:00 AM UTC
M
European session market picture: S&P 500 +0.04%, Nasdaq 100 -0.26%; EUR/USD +0.16%, WTI +0.8%, LLOY leads volume
European session market picture. US index futures: S and P futures is up 0.04 percent, Nasdaq futures is down 0.26 percent, Dow futures is up 0.27 percent and Russell futures is up 0.14 percent. In currencies, the dollar
EQUITY | Oct 20, 2026, 08:30 AM UTC
M
European session market picture: S&P 500 -0.01%, Nasdaq 100 -0.34%; EUR/USD +0.13%, WTI +0.83%, LLOY leads volume
European session market picture. US index futures: S and P futures is down 0.01 percent, Nasdaq futures is down 0.34 percent, Dow futures is up 0.18 percent and Russell futures is up 0.01 percent. In currencies, the doll
EQUITY | Oct 20, 2026, 08:00 AM UTC
M
FDA Grants Accelerated Approval to GSK’s Jemperli for Rectal Cancer
The FDA approved Jemperli for adults with MSI-H/dMMR stage II/III locally advanced rectal cancer, based on phase II AZUR-1 data. The review continues under Project Orbis.
REGULATION | Oct 19, 2026, 10:18 PM UTC
M
FDA Approves Jemperli for Locally Advanced Rectal Cancer
GSK received U.S. FDA approval for Jemperli (dostarlimab) for adults with MSI-H/dMMR locally advanced rectal cancer.
REGULATION | Oct 19, 2026, 06:24 PM UTC
M
European session market picture: S&P 500 +0.43%, Nasdaq 100 +1.08%; EUR/USD -0.11%, WTI -0.85%, LLOY leads volume
European session market picture. US index futures: S and P futures is up 0.43 percent, Nasdaq futures is up 1.08 percent, Dow futures is down 0.2 percent and Russell futures is up 0.44 percent. In currencies, the dollar
EQUITY | Oct 19, 2026, 12:00 PM UTC